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Abstract Fibronectin containing alternatively spliced
EIIIA and EIIIB domains is largely absent from mature
quiescent vessels in adults, but is highly expressed around
blood vessels during developmental and pathological
angiogenesis. The precise functions of fibronectin and its
splice variants during developmental angiogenesis however
remain unclear due to the presence of cardiac, somitic,
mesodermal and neural defects in existing global fibro-
nectin KO mouse models. Using a rare family of surviving
EIIIA EIIIB double KO mice, as well as inducible
endothelial-specific fibronectin-deficient mutant mice, we
show that vascular development in the neonatal retina is
regulated in an autocrine manner by endothelium-derived
fibronectin, and requires both EIIIA and EIIIB domains and
the RGD-binding a5 and av integrins for its function.
Exogenous sources of fibronectin do not fully substitute for
the autocrine function of endothelial fibronectin, demon-
strating that fibronectins from different sources contribute
differentially to specific aspects of angiogenesis.
Keywords Fibronectin  Angiogenesis  Integrins  EIIIA 
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Introduction
In addition to providing structural strength and elasticity to
blood vessels, the extracellular matrix (ECM) provides
instructional signals that control the development, pat-
terning, and stability of the vasculature [1]. The ECM
achieves this, in part, by binding and regulating the dis-
tribution and activity of growth factors such as the vascular
endothelial growth factors (VEGFs), platelet-derived
growth factor (PDGFs), fibroblast growth factor (FGFs)
and transforming growth factor-b (TGF-b) [2]. The ECM
also regulates vascular development by directly binding
and conveying both biochemical and biomechanical signals
through integrin receptors [3]. Integrins comprise a family
of heterodimeric adhesion receptors that contains 16a and
8b subunits that associate to form 24 different receptors
that bind to the ECM with distinct yet often overlapping
specificities. Previous studies have shown that the inter-
action of integrins with the ECM is essential for endothelial
cell (EC) adhesion and, as a consequence, regulates EC
proliferation, migration, and the sprouting of new vessels
[4]. Indeed, concentration gradients of immobilised ECM
proteins have been shown to control both the direction and
speed of EC migration in the absence of chemokines
in vitro [5, 6]. Furthermore, ECM-integrin interactions
have been shown to regulate EC junction formation, vessel
stability and integrity [7], cell polarity and vessel lumen
formation [8].
One of the most extensively studied ECM proteins
involved in vascular development is the glycoprotein
fibronectin (Fn) [9]. Fibronectin is a modular protein
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consisting of type I, II, and III repeating units and is
alternatively spliced to exclude extra EIIIA and EIIIB
domains, and portions of the variable (V or IIICS) domain.
Fibronectin is found only in vertebrates with an endothe-
lium-lined vasculature [10] and is expressed around early
embryonic vessels before the presence of other basement
membrane or structural ECM proteins [11, 12]. Interest-
ingly, Fn containing EIIIA and EIIIB domains is highly
expressed around angiogenic vessels [13, 14], but is largely
absent from mature quiescent vessels in adults until sub-
jected to injury or low or disturbed flow [15, 16], sug-
gesting that both domains are required for the development
and remodelling of the vasculature.
The functional importance of fibronectin can be seen
from several genetic studies [9]. Global deletion of Fn
leads to early embryonic lethality due to severe neural,
mesodermal, cardiac and vascular defects in mice
[12, 17, 18]. Individually EIIIA-null and EIIIB-null mice
are viable, fertile, and lack reported defects in either
developmental or tumour angiogenesis [19, 20], however
mice lacking both EIIIA and EIIIB domains die around
E10.5 with multiple developmental and cardiovascular
defects [21]. Interestingly, just as observed in Fn-null mice
and zebrafish (natter1 mutants), the severity of the defects
in EIIIA EIIIB double KO mice varies with genetic back-
ground, suggesting the presence of a genetic modi-
fier(s) [21–23]. The RGD motif within Fn, recognised by
a5b1 and av integrins (i.e. avb1, avb3, avb5, avb6 and
avb8), is also essential for embryonic development.
Replacement of the RGD by an inactive RGE motif leads
to neural, somitic and cardiovascular defects [17, 24],
while mice lacking endothelial expression of a5 and av
integrins, the major RGD-binding receptors expressed on
ECs, die around E14.5 with defects in the development of
the heart, great vessels and lymphatic vasculature [25, 26].
More recently, Fn secreted and assembled ahead of the
developing vasculature by astrocytes has been shown to
guide EC migration by binding and presenting VEGF to
EC tip cells [27], while Fn, including contributions from
plasma, has been shown to promote tumour angiogenesis
through increased retention of VEGF in the tumour envi-
ronment [28]. The precise role of endothelial-derived Fn in
developmental angiogenesis however remains unclear. Fn-
depleted ECs display defects in angiogenic assays in vitro
[29], however postnatal deletion of endothelial Fn fails to
inhibit tumour angiogenesis in mice [30].
To investigate further the role of fibronectin and its
alternatively spliced EIIIA and EIIIB domains in devel-
opmental angiogenesis in the absence of heart, great vessel,
somite, or neural crest defects, we have analysed in detail
the postnatal growth and patterning of blood vessels within
the retinas of inducible global Fn KO mice, EIIIA and
EIIIB double KO mice, and inducible endothelial-specific
Fn mutants. Our results show that vessel outgrowth,
branching, sprouting and stability are regulated to a sig-
nificant degree by EC-derived EIIIA?/EIIIB?-containing
fibronectin and require endothelial expression of either
a5b1 or the av integrins.
Methods
Mouse lines
All mice were housed and handled in accordance with
approved Massachusetts Institute of Technology Division
of Comparative Medicine protocols (IACUC approval
0412-033-15). Fn floxed [31], Itga5 floxed [26], Itgav
floxed [32], Rosa26-CreERT2 [33], Cdh5(PAC)-CreERT2
[34], and mTmG [35], mouse lines have all been described
previously. Live EIIIA/EIIIB KO mice were establish by
extensively backcrossing EIIIA/EIIIB heterozygous mice
[21] to C57BL/6 J wild-type mice and inter-crossing the
resulting mice at n = 10. Cre activity and gene deletion
were induced in FniKO and FniEC KO mice through con-
secutive intraperitoneal injections of 50 mg tamoxifen
(Sigma) at P1, P2 and P3. Genotyping was performed on
DNA isolated from tail snips in-house or by Transnetyx.
Immunofluorescence staining
Whole-mount immunofluorescence staining of retinas was
achieved following methods previously described in Pit-
ulescu et al. [36]. Briefly, eyes were freshly isolated and
fixed in 4% paraformaldehyde (PFA) in PBS at 4 C
overnight, blocked in PBS containing 0.5% Tween (PBS-
T) and 2% goat, donkey or fibronectin-depleted goat serum
and incubated overnight at 4 C with primary antibodies
either in 0.25% Tween/1% serum in PBS (staining buffer)
or, for isolectin-B4 staining, in Pblec buffer (1% Triton
X-100, 1 mM CaCl2, 1 mM MgCl2 and 1 mM MnCl2 in
PBS, pH 6.8). After washes in PBS, retinas were incubated
either at RT for 2 h, or overnight at 4 C, with fluorophore-
conjugated secondary antibodies diluted in staining buffer.
Retinas were then washed in PBS, cut into three segments
and flat-mounted onto coverslips in Fluoromount (Southern
Biotech).
Antibodies
Primary antibodies: Rat anti-mouse PECAM-1 MEC13.3
(1:100, BD Pharmingen), rabbit anti-Fibronectin (1:200,
Hynes lab) [16], mouse anti-EIIIA fibronectin antibody
(1:100, Abcam, IST-9), rabbit anti-Collagen IV (1:400,
Abcam, ab19808), rabbit anti-Desmin (1:200, Abcam,
ab15200), biotinylated Isolectin-B4 (1:50, Vector Labs,
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B-1205), mouse anti-EIIIB fibronectin (1:100, Amy
McMahon, Hynes lab). Secondary antibodies were Alex-
a488, Alexa594, and Alexa647 conjugated antibodies
(1:500, Invitrogen), and Alexa-Fluor–streptavidin-conju-
gated antibodies (1:200, Molecular Probes).
Image acquisition and processing
All images were acquired using Zeiss LSM 510 or Nikon
A1R scanning laser confocal microscopes and processed
using Volocity (Perkin Elmer) or Nikon Elements software
and Adobe Photoshop.
Quantitative analyses of the retinal vasculature
All quantifications were completed using Volocity (Perkin
Elmer) software using maximal intensity projection
images.
Radial outgrowth/vessel migration was measured in a
straight line from the optic nerve to the angiogenic front of
the retinal plexus in 6 different mice from each genotype
group (n = 6). Branch points were calculated from
250 lm 9 500 lm fields of view (FOV) adjacent to retinal
veins behind the angiogenic front using 6 different retina
samples from each genotype group (n = 6).
Endothelial coverage, tip cell sprouts, filopodial num-
bers and lengths were all measured using only isolectin-B4
stained retinas. Endothelial percentage coverage is defined
as the area of isolectin-B4-positive immunofluorescence
divided by the total area, and was calculated from 340 mm2
fields within the capillary plexus behind the angiogenic
front (n = 6 mice per genotype). Endothelial tip cell
numbers were quantified by counting endothelial sprouts at
the angiogenic front of the entire vascular plexus (n = 3
retinas per genotype). Endothelial tip cell filopodial num-
bers and lengths were calculated from high-resolution
confocal images (60X objective, thin z-sections of sample)
of 12 randomly selected tip cells at the leading edge of the
vascular plexus from a minimum of 3 retinas per genotype
(n = 12). Filopodia lengths were calculated from a mini-
mum of 50 filopodia (n = 50).
Fibronectin deposition around the vasculature was
quantified by measuring the mean fibronectin immunoflu-
orescent pixel intensity in 10 randomly selected PECAM1-
positive 500 lm2 fields within 200 lm of the leading edge
of the capillary plexus, using a minimum of 2 retinas per
genotype (n = 10). Vessel regression events were mea-
sured by counting PECAM1-/collagen IV? structures
within 6 FOV (sized 300 lm 9 300 lm) adjacent to the
retinal veins behind the angiogenic front using 3 retinas per
genotype (n = 6). Endothelial cell proliferation was cal-
culated by measuring the number of Ki-67? PECAM1?
cells within 2 retinas and normalising to 100 lm vessel
length (n = 2). Pericyte numbers were calculated from 6
fields (sized 230 lm 9 230 lm) within the capillary
plexus using a minimum of 3 retinas per genotype (n = 6).
Results are plotted as mean ± s.e.m and were analysed
using Student’s t test and considered significant when
*P\ 0.05, **P\ 0.01, ***P\ 0.001 or ****P\ 0.0001.
Results
Fibronectin controls the patterning of the retinal
vasculature
Fibronectin is highly expressed throughout the developing
retinal vasculature (Fig. 1a–f) and is assembled ahead of
the vascular plexus by retinal astrocytes (Fig. 1a–c)
forming a scaffold for ECs migration [27, 37]. In contrast
with the fibronectin assembled by astrocytes, the majority
of the fibronectin surrounding the vasculature contained the
alternatively spliced EIIIA and/or EIIIB
domain(s) (Fig. 1b–f), with expression of both EIIIA and
EIIIB especially pronounced around the edges of tran-
scapillary pillars (holes) in vessels undergoing intussus-
ceptive angiogenesis (Fig. 1d–f).
To investigate the role of fibronectin in regulating the
development of the retinal vasculature we first deleted Fn
from all postnatal tissue (FniKO) by administering tamox-
ifen to newborn mice carrying the inducible (ubiquitously
expressed) ROSA26-CreERT2 transgene and a loxP-flanked
Fn gene (Fig. S1a). Surprisingly, despite previous studies
showing that fibronectin is essential for early develop-
mental angiogenesis [12, 18, 38, 39], whole-mount
immunofluorescence staining of retinas revealed that both
Fnflox/flox mice (control) and Rosa26-CreERT2? Fnflox/flox
mutants (FniKO) develop a hierarchical vascular tree of
arteries, veins and capillaries by postnatal day 6 (P6)
(Fig. 2a–d). In contrast to control mice however, radial
growth and vessel branching were significantly compro-
mised in FniKO mice (Fig. 2a–f) and, as a consequence,
endothelial coverage within the retinal tissue was signifi-
cantly reduced (Fig. 2a–i). Since the EIIIA and EIIIB
domains of fibronectin have been shown to regulate vas-
cular morphogenesis [21], we next analysed the retinal
vasculature in a rare family of surviving C57BL/6 EIIIA-
EIIIB- double-knockout mice (FnAB KO). These mice
express fibronectin around their vasculature at equivalent
levels to control mice, however the Fn expressed no longer
contains the EIIIA and EIIIB domains (Fig. S1b). Inter-
estingly, phenocopying the FniKO mutants, FnAB KO mice
also displayed reduced vessel migration, branching and
coverage within their retinas at P6 (Fig. 2e–h). Because
EIIIA/EIIIB-containing fibronectin was predominantly
localised around the developing vasculature in control
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retinas (Fig. 1b–f), and branching defects have not been
reported in mice lacking astrocyte-derived fibronectin [27],
we next examined whether the defects in both the FniKO
and FnAB KO could be due to the loss of just EC-derived
EIIIA?/EIIIB? fibronectin. To avoid embryonic develop-
mental defects, we once again used an inducible loss-of-
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Fig. 1 Fibronectin localisation within the retinal vasculature. a–f
Whole-mount immunofluorescence staining showing the localisation
of fibronectin and its alternatively spliced EIIIA? and EIIIB? -
containing variants within the retinal vasculature of a P6 mouse.
Fibronectin is localised throughout the vasculature (a) and is
assembled just ahead of the vascular plexus by astrocytes (arrow-
heads a–c). EIIIA? (b) and EIIIB? (c) domains are present at low
levels in the fibronectin network assembled by astrocytes (arrow-
heads b, c), but are found at higher levels in the fibronectin
surrounding blood vessels. Note that expression of EIIIA (d, enlarged
in e) and EIIIB (f) are especially pronounced around the edges of
transcapillary pillars (holes) within vessels (arrows). Scale bars:
50 lm (a–d); 10 lm (e, f)
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function approach and deleted Fn expression specifically in
ECs from P1 onwards through the administration of
tamoxifen to mice carrying a Cdh5(PAC)-CreERT2 trans-
gene [34] and loxP-flanked Fn gene (FniEC KO). Just as
observed in FniKO and FnAB KO mice, radial expansion,
branching and density of retinal blood vessels were all
significantly reduced in FniEC KO mutants (Fig. 2f, g–i).
However, in contrast to both FniKO and FnAB KO mutants
(Fig. S1), and despite efficient Cre-mediated excision from
endothelial cells (Fig. S2), blood vessels in FniEC KO mice
remained covered with EIIIA?/EIIIB? fibronectin at sim-
ilar levels as observed in controls (Fig. 3a–c). This sup-
ports previous data showing that the majority of the
fibronectin deposited around the vasculature in the retina is
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Fig. 2 Abnormal patterning of the retinal vasculature in Fn mutants.
a–f Confocal micrographs of the retinal vasculature in control, FniKO,
FnAB KO and FniEC KO mice at P6. a, b Representative low
magnification images showing that, in the absence of fibronectin,
FniKO mice develop a vascular plexus containing arteries (A), veins
(V) and capillaries, but display reduced vessel outgrowth (dashed
lines illustrate measurements used to quantify distance of vessel
migration), vascular branching and vascular coverage in their retinas
(b, higher magnification c, d). These defects are phenocopied in
FnAB KO (e) and FniEC KO (f) mice. Quantification of vessel outgrowth
(g), vessel branching (h) and endothelial coverage (i) (see Methods)
reveals defects in the Fn mutants (n = 6, mice per genotype). Scale
bars: 500 lm (a, b), 100 lm (c–f)
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derived from astrocytes [27, 37], but suggests that astrocyte
fibronectin cannot compensate fully for the loss of
endothelial-derived fibronectin. Vessel patterning in the
retina therefore is regulated, at least in part, in an autocrine
manner by endothelial EIIIA?/EIIIB? fibronectin.
Endothelium-derived fibronectin affects tip cell
numbers in the retina
Examination of the leading edge of the vascular plexus
revealed that the reduced vessel density in all three Fn
mutants is, in part, due to a reduced number of tip cells at
the angiogenic front of the retinal vasculature (Fig. 4a–e).
In addition, global loss of fibronectin also led to increased
numbers of thick, long, abnormally shaped angiogenic
sprouts at the front of the plexus (Fig. 4a–d). Loss of
fibronectin did not appear however to affect either the
number or length of filopodia extending from individual tip
cells in Fn mutants (Fig. 4f, g). In addition, filopodia
extending from endothelial cells in FniEC KO mutants
aligned with the fibronectin network assembled ahead of
the plexus by the astrocytes (Fig. 3a).
Endothelium-derived fibronectin regulates vessel
stability
Further analysis revealed that EC-derived fibronectin also
has a critical role in controlling vessel stability. At P6,
FniEC KO mutants had increased numbers of thin empty
PECAM1-negative/collagen IV-positive basement mem-
brane sleeves, which are left behind by regressing
endothelial cells and serve as a historical record of pre-
existing vessels [40, 41], indicating increased pruning/re-
gression of vessels (Fig. 5a, b). Proliferation of endothelial
cells in FniEC KO mutants however appeared largely unaf-
fected by the loss of fibronectin (Fig. 5c, d). Previous
studies have shown that vessel stability is dependent on the
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Fig. 3 Deposition of fibronectin splice variants around the vessel
wall of FniEC KO mice. Whole-mount immunofluorescence staining
showing that FniEC KO mice develop vascular defects despite the
presence of exogenous EIIIA? (a) and EIIIB? (b) fibronectin
surrounding their vessels. c Quantification of fibronectin
immunofluorescence around the retinal vasculature of Fn mutants
showing that equivalent levels of fibronectin are deposited around the
vessels of control, FniEC KO and FnAB KO mice at P6 (n = 10, FOV).
NS not significant. Scale bars: 50 lm
cFig. 4 Fn mutants display reduced numbers of tip cells. Confocal
images of isolectin-B4-stained tip cells at the angiogenic front of
(a) control, (b) FniKO, (c) FnAB KO and (d) FniEC KO retinas at P6. Fn
mutants have reduced numbers of extending tip cell vessel sprouts
(n = 3, mice per genotype) (e), but have similar numbers of filopodial
extensions (n = 12, tip cells) (f) and filopodial lengths (n = 50,
filopodia) (g) per tip cell as control mice. Higher magnification
images of individual tip cells and filopodial extensions in right panels.
Note the thicker more irregular tip cell morphology in FniKO mutants
(a–d). NS not significant. Scale bars: 50 lm
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recruitment of mural cells [42], namely pericytes and
vascular smooth muscle cells. We therefore analysed
whether loss of EC-derived fibronectin inhibited the
recruitment and incorporation of mural cells around retinal
vessels. Analysis of P6 retinas stained with anti-desmin
antibodies however revealed no obvious defects in mural
cell recruitment or attachment to the capillaries of FniEC KO
mutants (Fig. 5e, f).
Mice lacking endothelial a5 and av integrins
phenocopy FniEC KO mutants
Since FniEC KO mice displayed vascular defects, despite
displaying apparently normal levels of cellular fibronectin
around their vessels (Fig. 3), we next investigated whether
vascular patterning in the retina is dependent on expression
of the major endothelial fibronectin-binding receptors,
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Fig. 5 Loss of EC-derived fibronectin leads to ectopic vessel
regression. a FniEC KO mice display increased numbers of thin,
empty (PECAM1-negative) sleeves of collagen IV matrix (arrows),
indicating increased levels of vessel regression within their retinas at
P6. b Quantification of PECAM1- collagen IV? vessel regression
segments (n = 6, FOV). c Immunofluorescence staining for the
proliferation marker Ki-67, and (d) quantification of proliferating
endothelial cells, revealed no significant differences in endothelial
cell (EC) proliferation within the retinas of FniEC KO mice at P6
(n = 2, mice per genotype). e Desmin-positive pericytes remain in
close association with the capillary endothelium in FniEC KO mice,
and are found in similar numbers to those seen in control mice
(f) (n = 6, FOV). Scale bars: 50 lm (a, e); 100 lm (c)
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integrin a5 and av. Just like fibronectin, a5 and av inte-
grins are poorly expressed on quiescent endothelium but
are highly expressed around blood vessels during devel-
opmental or tumour angiogenesis. Previous studies have
shown that mice lacking endothelial expression of both a5
and av die at E14.5 with heart, great vessel and lymphatic
defects [26, 43] but, in contrast to numerous in vitro
studies, lack angiogenic defects [26]. To examine the role
of endothelial a5 and av integrins in postnatal develop-
mental angiogenesis, we crossed female double-homozy-
gous Itga5/Itgav-floxed mice to Cdh5(PAC)-CreERT2 mice
(to generate Itga5/aviEC KO mice) and deleted both genes
from the endothelium through administration of tamoxifen
from P1 to bypass embryonic lethality. Despite the
requirement for both a5 and av integrins for fibronectin
fibrillogenesis in vitro, consistent with previous in vivo
studies [25, 26], Itga5/aviEC KO mice displayed no obvious
defects in the assembly of Fn around their vasculature
(Fig. 6a). However, just as observed in FniEC KO mutants,
doubly deficient Itga5/aviEC KO (but not singly deficient
Itga5iEC KO or ItgaviEC KO mice, data not shown) still
displayed reduced radial growth, vessel branching,
endothelial coverage, and tip cell numbers within their
retinas at P6 (Fig. 6b–g). Surprisingly, in contrast to mice
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Fig. 6 Loss of both endothelial a5 and av integrins phenocopies Fn
mutants. a Immunofluorescence staining showing deposition of
fibronectin around the retinal vasculature of an Itga5/aviEC KO mouse
at P6, despite the lack of the major fibronectin-binding integrins.
b Isolectin-B4-labeled retinas showing the decreased vessel branching
and density in Itga5/aviEC KO retinas. Quantification of (c) radial
outgrowth, (d) branchpoints and (e) endothelial coverage in Itga5/
aviEC KO mutants (n = 6, mice per genotype). f Representative image
of the tip-cell sprouts at the angiogenic front of the developing
vasculature in Itga5/aviEC KO mice. g Quantification of Itga5/aviEC KO
tip-cell deficit (n = 3, mice per genotype). Scale bars: 50 lm (a, b, f)
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in which Itga5 had been deleted from the endothelium
using Tie2-Cre [27], endothelial tip-cell filopodia appeared
unaffected by the loss of both a5 and av integrins and
aligned to the fibronectin network assembled by astrocytes
(Fig. 6a). The possibility exists that other fibronectin-
binding integrins could also be involved in retinal angio-
genesis or that they might partially compensate for the
absence of a5 and av. Nonetheless the results do show the
involvement of these two integrin subunits.
Discussion
In this study, we have shown that vessel patterning in the
retina is regulated in an autocrine manner by EC-derived
EIIIA?/EIIIB? fibronectin and that these functions are not
fully compensated by exogenous sources of fibronectin
such as astrocytes or plasma. We have also shown that
postnatal developmental angiogenesis requires endothelial
expression of at least one of the RGD-binding integrin
receptors and that interaction of a5 and av integrins with
EC-derived fibronectin regulates vessel sprouting and
vessel stability during vascular development.
Fibronectin regulates blood vessel development
It has long been suggested that fibronectin plays a key role
in the development of the vascular system. Fibronectin is
found only in vertebrates with an endothelial-lined vascu-
lature [10] and forms a central node within the ‘‘angiome’’
[44]. The exact functions of Fn and its splice variants
during vascular development however have remained
unclear due to mesodermal, neural tube and cardiac defects
hampering the interpretation of the vascular defects
observed in existing Fn models [12, 17, 18, 21]. Our
detailed analyses of retinal vascular development show
that, in the absence of embryonic defects, mice temporally
lacking Fn expression throughout the tissue develop severe
vascular patterning defects (Fig. 2). FniKO mice are able to
develop vessels, but radial expansion, vessel branching and
density of blood vessels are all reduced in the absence of
Fn (Fig. 2). While the reduced radial outgrowth of blood
vessels can in part be attributed to the loss of astrocyte-
derived Fn within the retina and reduced VEGFR2 and
PI3 K/Akt signalling [27], our results indicate that it is the
loss of EC-derived Fn that is the predominant cause of the
vascular defects observed. FniEC KO mutants display
decreased vessel outgrowth, branching, and vessel cover-
age, phenocopying the defects observed in global Fn KO
mice (Fig. 2). These defects are, at least in part, due to
decreased levels of vessel sprouting at the angiogenic front
(Fig. 4) and increased regression and pruning within the
vascular plexus (Fig. 5). Since Fn expression is especially
pronounced around the edges of transcapillary pillars, we
cannot however rule out the possibility that it may also
regulate intussusceptive angiogenesis, which has also been
shown to increase vessel branching and vascular expansion
in numerous tissues including the retina [45].
Cell autonomous roles for fibronectin
during vascular development
A remarkable finding in our study is that FniEC KO mice
develop vascular defects despite displaying apparently
normal levels of Fn around their vessels (Fig. 3), sug-
gesting that EC-derived Fn plays a distinct role in regu-
lating vascular development. During the development of
the retina, Fn is expressed by ECs, astrocytes [27, 37] and,
to some extent, pericytes [46], although the functional
importance of the latter appears to be minimal since no
defects have been observed in mice lacking pericyte
expression of Fn (data not shown). Astrocytes deposit a Fn
scaffold ahead of the vascular plexus to support EC
migration into the avascular areas of the retina (Fig. 1), but
upon contact with the advancing vasculature astrocytes
downregulate fibronectin expression [27, 37]. Interestingly,
in contrast to FniEC KO mutants, astrocyte-specific deletion
of Fn leads to increased numbers of tip-cell filopdia,
increased branching and an increase in vessel density [27].
Taken together, this suggests that Fn regulates vascular
development through distinct paracrine and autocrine
mechanisms, with astrocyte Fn inhibiting and EC-derived
Fn promoting sprouting and branching of vasculature.
Autocrine fibronectin has previously been suggested to
have a distinct role in controlling EC behaviour in vitro
[29], and has been shown to play an important role in
regulating cardiovascular development in vivo [47]. The
exact mechanisms by which autocrine Fn elicits its dif-
ferential response however remain unclear.
Roles of EIIIA/EIIIB-containing fibronectin
One possible hypothesis for the differential response to
paracrine and autocrine Fn is that ECs may produce a
different form of fibronectin. Fn containing EIIIA/EIIIB
domains is highly expressed around the developing vas-
culature, but these domains are almost undetectable in the
Fn scaffold deposited by astrocytes in the retina (Fig. 1).
Furthermore, loss of both EIIIA and EIIIB domains, but of
neither one alone (data not shown), replicates the vascular
defects observed in the FniEC KO mutants (Figs. 2, 4).
Arguing against this hypothesis however is the observation
that FniEC KO mutants still display EIIIA- and EIIIB-con-
taining fibronectin around their vessels (Fig. S1b). A caveat
of this analysis however is that it is almost impossible to
distinguish whether the Fn surrounding the vessels is
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EIIIA? EIIIB? or just fibrils of Fn containing a mixture of
EIIIA? EIIIB- and EIIIA- EIIIB? fibronectins. Since
neither EIIIA KO nor EIIIB single KO mice display any
vascular defects [19], it is possible that only EIIIA? EIIIB?
Fn is expressed by ECs, and it is this specific form of Fn
that is essential for regulating EC function. So, how might
the EIIIA and EIIIB domains regulate EC function? Pre-
vious studies have shown that Fn can bind and regulate the
activity of numerous growth factors [48], it is possible
therefore that the addition of EIIIA and EIIIB domains may
modulate growth factor signalling within the vascular
endothelium. Indeed, EIIIA and EIIIB KO cells have
reduced growth and proliferation in vitro [20, 49]. It is
unlikely that this is the cause of the vascular phenotype
seen in FniEC KO mice however, since no obvious prolif-
eration defects were observed in our mutant mice (Fig. 5).
A second possibility is that the addition of EIIIA and EIIIB
domains may alter the physiological properties of Fn.
Fibronectin is one of the most extendable biological fibres
[50, 51] and upon extension becomes more rigid [52]. It is
conceivable therefore that addition of EIIIA and EIIIB may
alter the structural and mechano-transductive properties of
the protein. Fn fibrillogenesis [53], assembly of collagen I
[54], and vasodilation of vessels [55] have all been shown
to be mechano-regulated by stretch-induced conforma-
tional changes in Fn. Finally, insertion of additional EIIIA
and EIIIB domains may increase adhesiveness of Fn to its
integrin receptors. The EIIIA domain contains additional
binding sites for a4b1 and a9b1 integrins [56], while
inclusion of EIIIB has been shown to induce a conforma-
tional change that unmasks a cryptic binding site [57] and
affects the exposure of the RGD loop [58] recognised by
both a5 and av integrins within Fn.
Role of a5 and av integrins during vascular
development
In contrast to studies in the embryo [26] and during
tumorigenesis [30], we found that endothelial expression of
both a5 and av integrins is essential for proper angiogen-
esis in the retina (Fig. 6). Just as observed in both FniEC KO
and FnAB KO mutants, loss of both a5 and av integrins
leads to defects in vessel growth, branching, and vascular
sprouting (Fig. 6). Interestingly, similar defects have been
reported in mice lacking EC expression of integrin b1 [7],
suggesting that interaction of EC-derived EIIIA? EIIIB?
Fn with a5b1 and avb1 regulates vessel patterning and
stability during retinal angiogenesis. We have previously
shown that a5 and av integrins cooperate to regulate vas-
cular smooth muscle cell function in vivo [25], it is
therefore increasingly clear that both receptors play a key
role(s) in controlling the development of the vascular
system. These results do not rule out the participation of
other integrins recognising fibronectin or, indeed, other
ECM proteins in retinal angiogenesis.
Conclusion
Very few prior studies have given much attention to the
cellular sources or specific splice variants of Fn within their
experiments. Our results have shown that EC-derived Fn
provides distinct signals from those derived from exoge-
nous sources of Fn (such as astrocytes, pericytes, and the
plasma) and is indispensible for proper vascular develop-
ment in the retina. Furthermore, we have shown that EC-
derived fibronectin requires both EIIIA and EIIIB domains
for its function and that it signals through a5 and av
integrins to regulate vessel patterning. It is quite possible
that detailed analyses of other angiogenic processes may
reveal analogous distinctions among the contributions of
different cell types and isoforms to specific aspects of
angiogenesis. The exact mechanisms by which EIIIA and
EIIIB domains within Fn regulate angiogenesis and the
precise roles of the individual Fn integrins on vascular cells
however remain unclear. Future experiments will need to
examine the biomechanical and biochemical signalling
changes caused by the addition of EIIIA and EIIIB
domains within fibronectin and use multiple inducible cell-
specific integrin and Fn mutants. It will also be important
to identify the genetic modifiers that strongly influence the
phenotypes of both integrin and fibronectin mutants.
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